---
title: "Roivant President, Immunovant CEO Eric Venker sells USD 6.99 million in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294281292.md"
description: "Roivant Sciences President and Immunovant CEO Eric Venker sold 200,000 common shares on July 27 at a weighted average price of $34.95, totaling approximately $6.99 million. On the same day, he exercised options for 200,000 shares at $3.85. Following these transactions, his directly held common shares decreased to 1,613,063, while his direct stock options increased to 4,044,834."
datetime: "2026-07-30T01:00:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294281292.md)
  - [en](https://longbridge.com/en/news/294281292.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294281292.md)
generator: "portal-rs"
---

# Roivant President, Immunovant CEO Eric Venker sells USD 6.99 million in common shares

-   Roivant Sciences President and Immunovant CEO Eric Venker sold 200,000 common shares on July 27 at a weighted average USD 34.95. \* He exercised options for 200,000 shares the same day at USD 3.85. \* Directly held common shares fell to 1,613,063. \* Directly held stock options rose to 4,044,834. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-030107), on July 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [IMVT.US](https://longbridge.com/en/quote/IMVT.US.md)
- [ROIV.US](https://longbridge.com/en/quote/ROIV.US.md)

## Related News & Research

- [Roivant Sciences President, Immunovant CEO Eric Venker disposes of common shares worth $7.15 million](https://longbridge.com/en/news/297713891.md)
- [Immunovant director Atul Pande disposes of 1,500 common shares worth $64,905](https://longbridge.com/en/news/297366091.md)
- [Algert Global LLC Raises Position in Immunovant, Inc. $IMVT](https://longbridge.com/en/news/297139502.md)
- [Bank of New York Mellon Corp Acquires New Stake in Immunovant, Inc. $IMVT](https://longbridge.com/en/news/297746838.md)
- [Mercury Systems CEO William L. Ballhaus sells USD 13.89 million in common shares](https://longbridge.com/en/news/297233246.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**